Immunobiology of Chemically Induced Tumors

  • Michael R. Price
  • Robert W. Baldwin
Part of the Cancer book series (C, volume 4)


A prerequisite to the analysis of cellular and humoral immune responses to neoantigens associated with chemically induced tumors is that their occurrence and specificity must be adequately defined. This has been achieved with a number of experimental tumor models, and, as indicated in a previous volume of this series, a major conclusion is that transformation by chemical carcinogens frequently results in the expression of neoantigens which function to promote tumor rejection reactions, although this is by no means a universal feature of chemical neoplasia (Baldwin and Price, Vol. 1, Chap. 12). Tumor-associated rejection antigens are, however, almost uniformly characterized by a high degree of specificity so that immunity to transplanted tumors in syngeneic hosts is directed only against cells of the immunizing tumor. There have proved to be very few exceptions to this, and individually specific neoantigens have even been demonstrated on cells transformed in vitro by chemical carcinogens (see Baldwin and Price, Vol. 1, Chap. 12, for further discussion of this point). One disparity recently observed has been with murine bladder tumors induced with 3-methylcholanthrene (MCA). With these, cross-reactivity was demonstrated by in vitro lymphocytotoxicity assays, although in tumor rejection tests individually distinct neoantigens were revealed (Taranger et al, 1972; Wahl et al., 1974).


Spleen Cell Tumor Immunity Tumor Rejection Peritoneal Exudate Cell Embryonic Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexander, P., 1974, Escape from immune destruction by the host through shedding of surface antigens: Is this a characteristic shared by malignant and embryonic cells? Cancer Res. 34:2077.PubMedGoogle Scholar
  2. Allison, A. C., Harrington, J. S., and Birbeck, M., 1966, An explanation of the cytotoxic effects of silica on macrophages. J. Exp. Med. 124:141.PubMedCrossRefGoogle Scholar
  3. Anderson, N. G., Holladay, D. W., Caton, J. E., Candler, E. L., Dierlam, P. J., Eveleigh, J. W., Ball, F. L., Holleman, J. W., Breillat, J. P., and Coggin, J. F., 1974, Searching for human tumor antigens, Cancer Res. 34:2066.PubMedGoogle Scholar
  4. Ankerst, J., Steele, G., and Sjögren, H. O., 1974, Cross-reacting tumor-associated antigen(s) of adenovirus type 9-induced fibroadenomas and a chemically induced mammary carcinoma in rats, Cancer Res. 34:1794.PubMedGoogle Scholar
  5. Baldwin, R. W., 1973, Immunological aspects of chemical carcinogenesis, Adv. Cancer Res. 18:1.PubMedCrossRefGoogle Scholar
  6. Baldwin, R. W., and Barker, C. R., 1967a, Tumor-specific antigenicity of aminoazo-dye-induced rat hepatomas, Int. J. Cancer 2:355.PubMedCrossRefGoogle Scholar
  7. Baldwin, R. W., and Barker, C. R., 1967b, Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata, Br. J. Cancer 21:793.PubMedCrossRefGoogle Scholar
  8. Baldwin, R. W., and Embleton, M. J., 1969a, Immunology of 2-acetylaminofluorene-induced rat mammary adenocarcinomas, Int. J. Cancer 4:47.PubMedCrossRefGoogle Scholar
  9. Baldwin, R. W., and Embleton, M. J., 1969b, Immunology of spontaneously arising rat mammary adenocarcinomas, Int. J. Cancer 4:430.PubMedCrossRefGoogle Scholar
  10. Baldwin, R. W., and Embleton, M. J., 1971a, Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas, Int. J. Cancer 7:17.PubMedCrossRefGoogle Scholar
  11. Baldwin, R. W., and Embleton, M. J., 1971b, Tumor-specific antigens in 2-acetylaminofluorene-induced rat hepatomas and related tumors, Israel J. Med. Sci. 7:144.PubMedGoogle Scholar
  12. Baldwin, R. W., and Embleton, M. J., 1974, Neoantigens on spontaneous and carcinogen-induced rat tumours defined by in vitro lymphocytotoxicity assays, Int. J. Cancer 13:433.PubMedCrossRefGoogle Scholar
  13. Baldwin, R. W., and Glaves, D., 1972, Solubilization of tumour-specific antigen from plasma membrane of an aminoazo-dye-induced rat hepatoma, Clin. Exp. Immunol. 11:51.PubMedGoogle Scholar
  14. Baldwin, R. W., and Moore, M., 1971, Tumour-specific antigens and tumour-host interactions, in: Immunological Tolerance to Tissue Antigens (N. W. Nisbet and M. W. Elves, eds.), pp. 299–313, Orthopaedic Hospital, Oswestry, England.Google Scholar
  15. Baldwin, R. W., Price, M. R., and Robins, R. A., 1972, Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes, Nature New Biol. 238:185.PubMedCrossRefGoogle Scholar
  16. Baldwin, R. W., Bowen, J. G., and Price, M. R., 1973a, Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serum, Brit. J. Cancer 28:16.PubMedCrossRefGoogle Scholar
  17. Baldwin, R. W., Embleton, M. J., and Moore, M., 1973b, Immunogenicity of rat hepatoma membrane fractions, Br. J. Cancer 28:389.PubMedCrossRefGoogle Scholar
  18. Baldwin, R. W., Embleton, M. J., and Price, M. R., 1973c, Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions, Int. J. Cancer 12:84.PubMedCrossRefGoogle Scholar
  19. Baldwin, R. W., Embleton, M. J., and Robins, R. A., 1973d, Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status, Int. J. Cancer 11:1.PubMedCrossRefGoogle Scholar
  20. Baldwin, R. W., Harris, J. R., and Price, M. R., 1973e, Fractionation of plasma membrane-associated tumour-specific antigen from an aminoazo dye-induced rat hepatoma, Int. J. Cancer 11:385.PubMedCrossRefGoogle Scholar
  21. Baldwin, R. W., Price, M. R., and Robins, R. A., 1973f, Significance of serum factors modifying cellular immune responses to growing tumours, Br. J. Cancer 28:37 (Suppl. I).Google Scholar
  22. Baldwin, R. W., Price, M. R., and Robins, R. A., 1973g, Inhibition of hepatoma-immune lymph node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen, Int. J. Cancer 11:527.PubMedCrossRefGoogle Scholar
  23. Baldwin, R. W., Bowen, J. G., Embleton, M. J., Price, M. R., and Robins, R. A., 1974a, Cellular and humoral immune interactions during neoplastic development, in: Role of Immunological Factors in Viral and Oncogenic Processes (R. F. Beers, R. C. Tilghman, and E. G. Bassett, eds.), pp. 393–407, Johns Hopkins University Press, Baltimore.Google Scholar
  24. Baldwin, R. W., Bowen, J. C., and Price, M. R., 1974b, Solubilization of membrane-associated tumour-specific antigens by β-glucosidase, Biochim. Biophys. Acta 367:47.PubMedCrossRefGoogle Scholar
  25. Baldwin, R. W., Embleton, M. J., Price, M. R., and Robins, R. A., 1974c, Immunity in the tumor-bearing host and its modification by serum factors, Cancer 34:1452.PubMedCrossRefGoogle Scholar
  26. Baldwin, R. W., Embleton, M. J., Price, M. R., and Vose, B. M., 1974d, Embryonic antigen expression on experimental rat tumours, Transplant. Rev. 20:77.PubMedGoogle Scholar
  27. Baldwin, R. W., Glaves, D., and Vose, B. M., 1974e, Immunogenicity of embryonic antigens associated with chemically induced rat tumours, Int. J. Cancer 13:135.PubMedCrossRefGoogle Scholar
  28. Baldwin, R. W., Glaves, D., and Vose, B. M., 1974f, Differentiation between the embryonic and tumour specific antigens on chemically induced rat tumours, Br. J. Cancer 29:1.PubMedCrossRefGoogle Scholar
  29. Bansal, S. C., and Sjögren, H. O., 1972, Counteraction of the blocking of cell-mediated tumor immunity by inoculation of unblocking sera and splenectomy: Immunotherapeutic effects on primary polyoma tumors in rats, Int. J. Cancer 9:490.PubMedCrossRefGoogle Scholar
  30. Bansal, S. C., and Sjögren, H. O., 1973a, Effects of BCG on various facets of the immune response against polyoma tumours in rats, Int. J. Cancer 11:162.PubMedCrossRefGoogle Scholar
  31. Bansal, S. C., and Sjögren, H. O., 1973b, Regression of polyoma tumor metastasis by combined unblocking and BCG treatment: Correlation with induced alterations in tumor immunity status, Int. J. Cancer 12:179.PubMedCrossRefGoogle Scholar
  32. Bansal, S. C., Hargreaves, R., and Sjögren, H. O., 1972, Facilitation of polyoma tumor growth in rats by unblocking sera and tumor eluate, Int. J. Cancer 9:97.PubMedCrossRefGoogle Scholar
  33. Bard, D. S., and Pilch, Y. H., 1969, The role of the spleen in immunity to a chemically induced sarcoma in C3H mice, Cancer Res. 29:1125.PubMedGoogle Scholar
  34. Bard, D. S., Hammond, W. G., and Pilch, Y. H., 1969, The role of the regional lymph nodes in the immunity to a chemically induced sarcoma in C3H mice, Cancer Res. 29:1379.PubMedGoogle Scholar
  35. Basham, C., and Currie, G. A., 1974, Development of specific cell-dependent antibody during growth of a syngeneic rat sarcoma, Br. J. Cancer 29:189.PubMedCrossRefGoogle Scholar
  36. Belehradek, J., Barski, G., and Thonier, M., 1972, Evolution of cell mediated antitumour immunity in mice bearing a syngeneic chemically induced tumor: Influence of tumor growth, surgical removal and treatment with irradiated tumor cells, Int. J. Cancer 9:461.PubMedCrossRefGoogle Scholar
  37. Blair, P. B., and Lane, M. A., 1974, Serum factors in mammary neoplasia; Enhancement and antagonism of spleen cell activity in vitro detected by different methods of serum factor assay, J. Immunol. 112:439.PubMedGoogle Scholar
  38. Blasecki, J. W., and Tevethia, S. S., 1975, In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells, J. Immunol. 114:244.PubMedGoogle Scholar
  39. Bloom, E. T., 1970, Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene, J. Natl. Cancer Inst. 45:443.PubMedGoogle Scholar
  40. Bloom, E. T., and Hildemann, W. H., 1970, Mechanisms of tumor-specific enhancement versus resistance toward a methylcholanthrene-induced murine sarcoma, Transplantation 10:321.PubMedCrossRefGoogle Scholar
  41. Borsos, T., Richardson, A. K., Ohanian, S. H., and Leonard, E. J., 1973, Immunochemical detection of tumor-specific and embryonic antigens of diethylnitrosamine-induced guinea pig tumors, J. Natl. Cancer Inst. 51:1955.PubMedGoogle Scholar
  42. Bowen, J. G., Robins, R. A., and Baldwin, R. W., 1974, Serum factors modifying cell mediated immunity to rat hepatoma D23 correlated with tumour status, Int. J. Cancer 15:640.CrossRefGoogle Scholar
  43. Brawn, R. J., 1970, Possible association of embryonal antigen(s) with several primary 3-methylcholanthrene-induced murine sarcomas, Int. J. Cancer 6:245.PubMedCrossRefGoogle Scholar
  44. Bubeník, J., and Koldovsky, P., 1964, The mechanism of antitumour immunity studied by means of transfers of immunity, Folia Biol. (Prague) 10:427.Google Scholar
  45. Burdick, J. F., Cohen, A. M., and Wells, S. A., 1973, A simplified isotopic antiglobulin assay: Detection of tumor cell antigens, J. Natl. Cancer Inst. 50:285.PubMedGoogle Scholar
  46. Cerottini, J.-C., Nordin, A. A., and Brunner, K. T., 1972, In vitro cytotoxic activity of thymus cells, sensitized to alloantigens, Nature (London) 227:72.CrossRefGoogle Scholar
  47. Chandradasa, K. D., 1973, The development of specific suppression of concomitant immunity in two syngeneic tumor-host systems, Int. J. Cancer 11:648.PubMedCrossRefGoogle Scholar
  48. Chia, E., and Festenstein, H., 1973, Specific cytostatic effect of lymph node cells from normal and T-cell deficient mice on syngeneic tumour target cells in vitro, and its specific abrogation by syngeneic fluid from tumour-bearing mice, Eur. J. Immunol. 3:483.PubMedCrossRefGoogle Scholar
  49. Cleveland, P. H., Mckhann, C. F., Johnson, K., and Nelson, S., 1974, A microassay for humoral cytotoxicity demonstrating sublethal effects of antibody, Int. J. Cancer 14:417.PubMedCrossRefGoogle Scholar
  50. Cohen, A. M., Burdick, J. F., and Ketcham, A. S., 1971, Cell-mediated cytotoxicity: An assay using 125I-iododeoxyuridine-labeled target cells, J. Immunol. 107:895.PubMedGoogle Scholar
  51. Cohen, A. M., Millar, R. C., and Ketcham, A. S., 1972, Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma, Cancer Res. 32:2421.PubMedGoogle Scholar
  52. Cohen, J. M., Yang, S. S., and Law, L. W., 1974, Abrogation of cell-mediated immunity by hyperimmune alloantiserum: Mechanisms and correlation with allograft enhancement, Int. J. Cancer 13:463.PubMedCrossRefGoogle Scholar
  53. Currie, G. A., 1973, The role of circulating antigen as an inhibitor of tumour immunity in man, Br. J. Cancer 28:153 (Suppl. I).Google Scholar
  54. Currie, G. A., and Alexander, P., 1974, Spontaneous shedding of TSTA by viable sarcoma cells: Its possible role in facilitating metastatic spread, Br. J. Cancer 29:72.PubMedCrossRefGoogle Scholar
  55. Currie, G. A., and Basham, C., 1972, Serum-mediated inhibition of the immunological reactions of the patient to his own tumour: A possible role for circulating antigen, Br. J. Cancer 26:427.PubMedCrossRefGoogle Scholar
  56. Datta, S. K., and Vandeputte, M., 1971, Studies on cellular and humoral immunity to tumor-specific antigens in polyoma virus-induced tumors of rats, Cancer Res. 31:882.Google Scholar
  57. Davies, D. A. L., Buckham, S., and Manstone, A. J., 1974a, Protection of mice against syngeneic lymphomata. II. Collaboration between drugs and antibodies, Br. J. Cancer 30:305.PubMedCrossRefGoogle Scholar
  58. Davies, D. A. L., Manstone, A. J., and Buckham, S., 1974b, Protection of mice against syngeneic lymphomata. I. Use of antibodies, Br. J. Cancer 30:297.PubMedCrossRefGoogle Scholar
  59. Deckers, P. J., Edgerton, B. W., Thomas, B. S., and Pilch, Y. H., 1971, The adoptive transfer of concomitant immunity to murine tumor isografts with spleen cells from tumor-bearing animals, Cancer Res. 31:734.PubMedGoogle Scholar
  60. Evans, R., and Alexander, P., 1972, Mechanism of immunologically specific killing of tumour cells by macrophages. Nature (London) 236:168.CrossRefGoogle Scholar
  61. Evans, R., Cox, H., and Alexander, P., 1973, Immunologically specific activation of macrophages armed with specific macrophage arming factor, Proc. Soc. Exp. Biol. (N. Y.) 143:256.Google Scholar
  62. Fefer, A., 1969, Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice, Cancer Res. 29:2177.PubMedGoogle Scholar
  63. Fisher, B., Saffer, E. A., and Fisher, E. R., 1970, Comparison of concomitant and sineconcomitant tumor immunity, Proc. Soc. Exp. Biol. (N.Y.) 135:68.Google Scholar
  64. Forman, J., and Möller, G., 1973, The effector cell in antibody induced cell mediated immunity, Transplant. Rev. 17:108.PubMedGoogle Scholar
  65. Glaser, M., Herberman, R. B., Kirchner, H., and Djeu, J. Y., 1974, Study of the cellular immune response to Gross virus-induced lymphoma by the mixed lymphocyte-tumor interaction, Cancer Res. 34:2165.PubMedGoogle Scholar
  66. Greenberg, A. H., and Shen, L., 1973, A class of specific cytotoxic cells demonstrated in vitro by arming with antigen-antibody complexes, Nature New Biol. 245:282.PubMedGoogle Scholar
  67. Halliday, W. J., 1971, Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens, J. Immunol. 106:855.PubMedGoogle Scholar
  68. Halliday, W., and Webb, M., 1969, Delayed hypersensitivity to chemically induced tumors in mice and correlation with an in vitro test, J. Natl. Cancer Inst. 43:141.PubMedGoogle Scholar
  69. Halliday, W. J., Maluish, A., and Miller, S., 1974, Blocking and unblocking of cell-mediated antitumor immunity in mice, as detected by the leucocyte adherence inhibition test, Cell. Immunol. 10:467.PubMedCrossRefGoogle Scholar
  70. Harada, M., Pearson, G., Pettigrew, H., Redmon, L., and Orr, T., 1973, Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens, Cancer Res. 33:2886.PubMedGoogle Scholar
  71. Harder, F. H., and Mckhann, C. F., 1968, Demonstration of cellular antigens on sarcoma cells by an indirect 125I-labeled antibody technique, J. Natl. Cancer Inst. 40:231.PubMedGoogle Scholar
  72. Hellström, I., 1967, A colony inhibition (CI) technique for demonstration of tumor cell destruction by lymphoid cells in vitro, Int. J. Cancer 2:65.PubMedCrossRefGoogle Scholar
  73. Hellström, I., and Hellström, K. E., 1969, Studies on cellular immunity and its serum-medicated tumor-cell destruction by certain patient sera, Int. J. Cancer 12:348.CrossRefGoogle Scholar
  74. Hellström, I., and Hellström, K. E., 1970a, Colony inhibition studies on blocking and non-blocking serum effects on cellular immunity to Moloney sarcomas, Int. J. Cancer 5:195.PubMedCrossRefGoogle Scholar
  75. Hellström, I., Hellström, K. E., and Pierce, G. E., 1968, In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs, Int. J. Cancer 3:467.PubMedCrossRefGoogle Scholar
  76. Hellström, I., Hellström, K. E., and Sjögren, H. O., 1970, Serum-mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas, Cell. Immunol. 1:18.PubMedCrossRefGoogle Scholar
  77. Hellström, I., Hellström, K. E., and Warner, G. A., 1973, Increase of lymphocyte-mediated tumor-cell destruction by certain patient sera, Int. J. Cancer 12:348.PubMedCrossRefGoogle Scholar
  78. Hellström, K. E., and Hellström, I., 1970b, Immunological enhancement as studied by cell culture techniques, Ann. Rev. Microbiol. 24:373.CrossRefGoogle Scholar
  79. Hellström, K. E., and Hellström, I., 1974, Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens, Adv. Immunol. 18:209.PubMedCrossRefGoogle Scholar
  80. Henderson, W. R., Fukuyama, K., Epstein, W. L., and Spitler, L. E., 1973, Blocking of a cellular immune reaction to malignant melanoma by immunoglobulin from tumor-bearing animals, J. Reticuloendothel. Soc. 13:155.PubMedGoogle Scholar
  81. Herberman, R. B., and Oren, M. E., 1971, Immune responses to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response, J. Natl. Cancer Inst. 46:391.PubMedGoogle Scholar
  82. Herberman, R. B., Ting, C. C., Kirchner, H., Holden, H., Glaser, M., Bonnard, G. D., and Lavrin, D., 1974, Effector mechanisms in tumor immunity, in: Progress in Immunology, Vol. II, Academic Press, New York.Google Scholar
  83. Hersey, P., 1973, New look at antiserum therapy of leukaemia, Nature New Biol. 244:22.PubMedCrossRefGoogle Scholar
  84. Ishidate, M., 1967, Recognition of the individuality of tumour strain by peritoneal lymphoid cells, Nature (London) 215:184.CrossRefGoogle Scholar
  85. Jagarlamoody, S., Aust, J. C., Tew, R. H., and Mckhann, C. F., 1970, Tumor-specific immunity assayed in vitro by cell growth inhibition, Proc. Am. Assoc. Cancer Res. 11:40.Google Scholar
  86. Jose, D. G., and Seshadri, R., 1974, Circulating immune complexes in human neuroblastoma: Direct assay and role in blocking specific cellular immunity, Int. J. Cancer 13:824.PubMedCrossRefGoogle Scholar
  87. Jose, D. G., and Skvaril, F., 1974, Serum inhibitors of cellular immunity in human nephroblastoma: IgG subclass of blocking activity, Int. J. Cancer 13:173.PubMedCrossRefGoogle Scholar
  88. Kolb, J. P., Poupon, M. F., and Lespinats, G., 1974, Tumor-associated antigen (TAA) and anti-TAA antibodies in the serum of BALB/c mice with plasmacytomas, J. Natl. Cancer Inst. 52:723.PubMedGoogle Scholar
  89. Krahenbuhl, J. L., and Remington, J. S., 1974, The role of activated macrophages in specific and non specific cytostatis of tumor cells, J. Immunol. 113:507.PubMedGoogle Scholar
  90. Lamon, E. W., Klein, E., Andersson, B. Fenyö, E. M., and Skurzak, H. M., 1973a, The humoral antibody response to a primary viral neoplasm (MSV) through its entire course, Int. J. Cancer 12:637.PubMedCrossRefGoogle Scholar
  91. Lamon, E. W., Wigzell, H., Andersson, B., and Klein, E., 1973b, Anti-tumour cell activity in vitro dependent on immune B lymphocytes, Nature New Biol. 244:209.PubMedGoogle Scholar
  92. Lamon, E. W., Wigzell, H., Klein, E., Andersson, B., and Skurzak, H., 1973c, The lymphocyte response to primary Moloney sarcoma virus tumors in Balb/c mice: Definition of the active subpopulations at different times after infection, J. Exp. Med. 137:1472.PubMedCrossRefGoogle Scholar
  93. Lamon, E. W., Andersson, B., Wigzell, H., Fenyö, E. M., and Klein, E., 1974, The immune response to primary Moloney sarcoma virus tumors in BALB/c mice: Cellular and humoral activity of long-term regressors, Int. J. Cancer 13:91.PubMedCrossRefGoogle Scholar
  94. Lausch, R. N., and Rapp, F., 1969, Concomitant immunity in hamsters bearing DMBA-induced tumor transplants, Int. J. Cancer 4:226.PubMedCrossRefGoogle Scholar
  95. Laux, D., and Lausch, R. N., 1974, Reversal of tumor-mediated suppression of immune reactivity by in vitro incubation of spleen cells, J. Immunol. 112:1900.PubMedGoogle Scholar
  96. Leclerc, J. C., Gomard, E., Plata, F., and Levy, J. P., 1973, Cell-mediated immune reaction against tumors induced by oncornaviruses: Nature of the effector cells in tumor cell cytolysis, Int. J. Cancer 11:426.PubMedCrossRefGoogle Scholar
  97. Le Mevel, B. P., and Wells, S. A., 1973, A microassay for the quantitation of cytotoxic antitumor antibody; Use of 125I-Iododeoxyuridine as a tumor cell label, J. Natl. Cancer Inst. 50:803.Google Scholar
  98. Le Mevel, B. P., Oldham, R. K., Wells, S. A., and Herberman, R. B., 1973, An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity, J. Natl. Cancer Inst. 51:1551.PubMedGoogle Scholar
  99. Littman, B. H., Meltzer, M. S., Cleveland, R. P., Zbar, B., and Rapp, H. J., 1973, Tumor-specific, cell-mediated immunity in guinea pigs with tumors, J. Natl. Cancer Inst. 51:1627.PubMedGoogle Scholar
  100. Lohmann-Matthes, M. L., and Fisher, H., 1973, T-cell cytotoxicity and amplification of the cytotoxic reaction by macrophages, Transplant. Rev. 17:150.PubMedGoogle Scholar
  101. Maclennan, I. C. M., 1972, Antibody in the induction and inhibition of lymphocyte cytotoxicity, Transplant. Rev. 13:67.PubMedGoogle Scholar
  102. Maluish, A., and Halliday, W. J., 1974, Cell-mediated immunity and specific serum factors in human cancer: The leukocyte adherence inhibition test, J. Natl. Cancer Inst. 52:1415.PubMedGoogle Scholar
  103. Mccoy, J. L., Dean, J. H., Law, L. W., Williams, J., Mccoy, N. T., and Holiman, B. J., 1974, Immunogenicity, antigenicity and mechanisms of tumor rejection of mineral oil induced plasmacytomas in syngeneic BALB/c mice, Int. J. Cancer 14:264.PubMedCrossRefGoogle Scholar
  104. Meltzer, M. S., Oppenheim, J. J., Littman, B. H., Leonard, E. J., and Rapp, H. J., 1972, Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens, J. Natl. Cancer Inst. 49;727.PubMedGoogle Scholar
  105. Menard, S., Pierotti, M., and Colnaghi, M. I., 1972, A 51Cr microtest for cellular immunity, Transplantation 14:155.PubMedCrossRefGoogle Scholar
  106. Mikulska, Z. B., Smith, C., and Alexander, P., 1966, Evidence for an immunological reaction of the host directed against its own actively growing primary tumor, J. Natl. Cancer Inst. 36:29.PubMedGoogle Scholar
  107. Möller, G., 1964, Effect on tumour growth in syngeneic recipients of antibodies against tumour-specific antigens in methylcholanthrene-induced mouse sarcomas, Nature (London) 204:846.CrossRefGoogle Scholar
  108. Möller, G., and Svehag, S. E., 1972, Specificity of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells, Cell. Immunol. 4:1.PubMedCrossRefGoogle Scholar
  109. Nelson, D. S., 1974, Immunity to infection, allograft immunity and tumour immunity: Parallels and contrasts, Transplant. Rev. 19:226.PubMedGoogle Scholar
  110. Old, L. J., and Boyse, E. A., 1964, Immunology of experimental tumors, Ann. Rev. Med. 15:167.PubMedCrossRefGoogle Scholar
  111. Old, L. J., Boyse, E. A., Clarke, D. A., and Carswell, E. A., 1962, Antigenic properties of chemically induced tumors, Ann. N.Y. Acad. Sci. 101:80.CrossRefGoogle Scholar
  112. Oren, M. E., Herberman, R. B., and Canty, T. G., 1971, Immune response to Gross virus-induced lymphoma. II. Kinetics of the cellular immune response, J. Natl. Cancer Inst. 46:621.PubMedGoogle Scholar
  113. Ortiz de Landazuri, M. and Herberman, R. B., 1972, In vitro activation of cellular immune response to Gross virus-induced lymphoma, J. Exp. Med. 136:969.CrossRefGoogle Scholar
  114. Ortiz de Landazuri, M., Kedar, E., and Fahey, J. L., 1974, Antibody-dependent cellular cytotoxicity to a syngeneic Gross virus-induced lymphoma, J. Natl. Cancer Inst. 52:147.Google Scholar
  115. Perlmann, P., Perlmann, H., and Wigzell, H., 1972, Lymphocyte mediated cytotoxicity in vitro: Induction and inhibition by humoral antibody and nature of effector cells. Transplant. Rev. 13:91.PubMedGoogle Scholar
  116. Perlmann, P., Wigzell, H., Goldstein, P., Lamon, E. W., Larsson, A., O’Toole, C., Perlmann, H., and Svedmyr, E. A. J., 1974, Cell-mediated cytolysis in vitro: Analysis of active lymphocyte subpopulations in different experimental systems, Adv. Biosci. 12:71.Google Scholar
  117. Plata, F., and Levy, J. P., 1974, Blocking of syngeneic effector T cells by soluble tumour antigens, Nature (London) 249:271.CrossRefGoogle Scholar
  118. Plata, F., Gomard, E., Leclerc, J. C., and Levy, J. P., 1973, Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis, J. Immunol. 111:667.PubMedGoogle Scholar
  119. Pollack, S., and Nelson, K., 1974, Early appearance of lymphoid arming factor and cytotoxic lymph node cells after tumor induction, Int. J. Cancer 14:522.PubMedCrossRefGoogle Scholar
  120. Prehn, R. T., and Lappé, M. A., 1971, An immunostimulation theory of tumor development, Transplant. Rev. 7:26.PubMedGoogle Scholar
  121. Price, M. R., 1974, Isolation of embryonic antigens from chemically induced rat hepatomas, Biochem. Soc. Trans. 2:650.Google Scholar
  122. Price, M. R., and Baldwin, R. W., 1974a, Preparation of aminoazo dye-induced rat hepatoma membrane fractions retaining tumour specific antigen, Br. J. Cancer 30:382.PubMedCrossRefGoogle Scholar
  123. Price, M. R., and Baldwin, R. W., 1974b, Immogenic properties of rat hepatoma subcellular fractions, Br. J. Cancer 30:394.PubMedCrossRefGoogle Scholar
  124. Rapp, H. J., Churchill, W. H., Kronman, B. S., Rolley, R. T., Hammond, W. G., and Borsos, T., 1968, Antigenicity of a new diethylnitrosamine-induced transplantable guinea pig hepatoma: Pathology and formation of ascites variant, J. Natl. Cancer Inst. 41:1.PubMedGoogle Scholar
  125. Rees, R. C., Price, M. R., Baldwin, R. W., and Shah, L. P., 1974a, Inhibition of rat lymph node cell cytotoxicity by hepatoma-associated embryonic antigen, Nature (London) 252:751.CrossRefGoogle Scholar
  126. Rees, R. C., Price, M. R., Shah, L. P., and Baldwin, R. W., 1974b, Detection of hepatoma-associated embryonic antigen in tumour-bearer serum, Transplantation 19:424.CrossRefGoogle Scholar
  127. Ritter, J., Lohmann-Matthes, M.-L., and Fisher, H., 1973, Specific inactivation of cytotoxic lymphocytes after adsorption on 51Cr labeled fibroblast monolayers, Transplantation 16:579.PubMedGoogle Scholar
  128. Robins, R. A., and Baldwin, R. W., 1974, Tumour specific antibody neutralization of factors in rat hepatoma bearer serum which abrogate lymph node cell cytotoxicity, Int. J. Cancer, 14:589.PubMedCrossRefGoogle Scholar
  129. Rosenberg, E. B., Hill, J., Ferarri, A., Herberman, R. B., Ting, C.-C., Mann, D. L., and Fahey, J., 1973, Prolonged survival of tumor allografts in mice pretreated with soluble transplantation antigens, J. Natl. Cancer Inst. 50:1453.PubMedGoogle Scholar
  130. Rouse, B. T., Röllonghoff, M., and Warner, N. L., 1972, Anti-θ serum-induced suppression of cellular transfer of tumour-specific immunity to a syngeneic plasma cell tumour, Nature (London) 238:116.Google Scholar
  131. Rouse, B. T., Röllinghoff, M., and Warner, N. L., 1973, Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response, Eur. J. Immunol. 3:218.PubMedCrossRefGoogle Scholar
  132. Rubin, B. A., 1971, Alteration of the homograft response as a determinant of carcinogenicity, Progr. Exp. Tumor Res. 14:138.PubMedGoogle Scholar
  133. Rudman, D., Del Rio, A., Akgun, S., and Frumin, E., 1969, Novel proteins and peptides in the urine of patients with advanced neoplastic disease, Am. J. Med. 46:174.PubMedCrossRefGoogle Scholar
  134. Senik, A., DE Giorgi, L., Gomard, E., and Levy, J. P., 1974a, Cytostasis of lymphoma cells in suspension: Probable non-thymic origin of the cytostatic lymphoid cells in mice bearing MSV-induced tumors, Int. J. Cancer 14:396.PubMedCrossRefGoogle Scholar
  135. Senik, A., DE Giorgi, L., and Levy, J. P., 1974b, Cell-mediated anti-tumor immunity in oncornavirus-induced tumors: Specific cytostasis of tumor cells by spleen and lymph node cells, Int. J. Cancer 14:386.PubMedCrossRefGoogle Scholar
  136. Shellam, G. R., 1974, Studies on a Gross-virus-induced lymphoma in the rat. I. The cell-mediated immune response, Int. J. Cancer 14:65.PubMedCrossRefGoogle Scholar
  137. Shortman, K., Byrd, W., Williams, N., Brunner, K. T., and Cerottini, J.-C., 1972, Separation of different cell classes from lymphoid organs, Aust. J. Exp. Biol. Med. Sci. 50:323.PubMedCrossRefGoogle Scholar
  138. Sjögren, H. O., and Borum, K., 1971, Tumor-specific immunity in the course of primary polyoma and Rous tumor development in intact and immunosuppressed rats, Cancer Res. 31:890.PubMedGoogle Scholar
  139. Sjögren, H. O., Hellström, I., Bansal, S. C., and Hellström, K. E., 1971, Suggestive evidence that the “blocking antibodies” of tumor bearing individuals may be antigen-antibody complexes, Proc. Natl. Acad. Sci. 68:1372.PubMedCrossRefGoogle Scholar
  140. Sjögren, H. O., Hellström, I., Bansal, S. C., Warner, G. A., and Hellström, K. E., 1972, Elution of “blocking antibodies” from human tumors, capable of abrogating tumor cell destruction by specifically immune lymphocytes, Int. J. Cancer 9:274.PubMedCrossRefGoogle Scholar
  141. Skurzak, H. M., Klein, E., Yoshida, T. O., and Lamon, E. W., 1972, Synergistic or antagonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system, J. Exp. Med. 135:997.PubMedCrossRefGoogle Scholar
  142. Steele, G., Ankerst, J., and Sjögren, H. O., 1974, Alteration of in vitro antitumor activity of tumor bearer serum by absorption with Staphylococcus aureus, Cowan I, Int. J. Cancer 14:83.PubMedCrossRefGoogle Scholar
  143. Stutman, O., 1974, Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice, Science 183:534.PubMedCrossRefGoogle Scholar
  144. Takasugi, M., and Klein, E., 1970, A microassay for cell-mediated immunity, Transplantation 9:219.PubMedCrossRefGoogle Scholar
  145. Takeda, K., Aizawa, M., Kituchi, Y., Yamawaki, S., and Naramura, K., 1966, Tumour autoimmunity against methylcholanthrene-induced sarcomas of the rat, Gann 57:221.PubMedGoogle Scholar
  146. Tamerius, J. D., and Hellström, I., 1974, In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells, J. Immunol. 112:1987.PubMedGoogle Scholar
  147. Taranger, L. A., Chapman, W. H., Hellström, I., and Hellström, K. E., 1972, Immunological studies on urinary bladder tumors of rats and mice, Science 176:1337.PubMedCrossRefGoogle Scholar
  148. Thomson, D. M. P., Eccles, S., and Alexander, P., 1973a, Antibodies and soluble tumour-specific antigens in blood and lymph of rats with chemically induced sarcomata, Br. J. Cancer 28:6.PubMedCrossRefGoogle Scholar
  149. Thomson, D. M. P., Sellens, V., Eccles, S., and Alexander, P., 1973b, Radioimmunoassay of tumor-specific transplantation antigen of a chemically-induced rat sarcoma: Circulating soluble tumour antigen in tumour bearers, Brit. J. Cancer 28:377.PubMedCrossRefGoogle Scholar
  150. Tigelaar, R. E., and Gorczynski, R. M., 1974, Separable populations of activated thymus-derived identified in two assays for cell-mediated immunity to murine tumor allografts, J. Exp. Med. 140:267.PubMedCrossRefGoogle Scholar
  151. Todd, R. F., Stulting, R. D., and Berke, G., 1973, Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells, Cancer Res. 33:3203.PubMedGoogle Scholar
  152. Vaage, J., 1971, Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue, Cancer Res. 31:1655.PubMedGoogle Scholar
  153. Vaage, J., 1972, Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice, Cancer Res. 32:193.PubMedGoogle Scholar
  154. Vasudevan, D. M., Brunner, K. T., and Cerottini, J.-C., 1974, Detection of cytotoxic T lymphocytes in the EL4 mouse leukemia system: Increased activity of immune spleen and peritoneal cells following preincubation and cell fractionation procedures, Int. J. Cancer 14:301.PubMedCrossRefGoogle Scholar
  155. Voisin, G. A., 1971, Immunological facilitation, a broadening of the concept of the enhancement phenomenon, in: Progress in Allergy, Vol. 15 (P. Kallós, B. H. Waksman, and A. de Weck, eds.), pp. 328–485, Karger, Basel.CrossRefGoogle Scholar
  156. Wagner, H., Harris, A. W., and Feldmann, H., 1972, Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes, Cell. Immunol. 4:39.PubMedCrossRefGoogle Scholar
  157. Wagner, H., Röllinghoff, M., and Nossal, G. J. V., 1973, T-cell-mediated immune responses induced in vitro: A probe for allograft and tumor immunity, Transplant. Rev. 17:3.PubMedGoogle Scholar
  158. Wahl, D. V., Chapman, I., Hellström, I., and Hellström, K. E., 1974, Transplantation immunity to individually unique antigens of chemically induced bladder tumors in mice, Int. J. Cancer 14:114.PubMedCrossRefGoogle Scholar
  159. Winn, H. J., 1961, Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts, J. Immunol. 86:228.PubMedGoogle Scholar
  160. Witz, I., 1973, The biological significance of tumor-bound immunoglobulins, in: Current Topics in Microbiology and Immunology, Vol. 61 (W. Arber, R. Haas, W. Henle, P. H. Hof Schneider, N. K. Jerne, P. Koldovsky, H. Koprowski, O. Maalø, R. Rott, H. G. Schweiger, M. Sela, L. Syrucek, P. K. Vogt and E. Wecker, eds.), pp. 151–171, Springer, Berlin.Google Scholar
  161. Zarling, J., and Tevethia, S. S., 1973, Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection, J. Natl. Cancer Inst. 50:149.PubMedGoogle Scholar
  162. Zbar, B., Wepsic, H. T., Rapp, H. J., Borsos, T., Kronman, B. S., and Churchill, W. H., 1969, Antigenic specificity of hepatomas induced in strain-2 guinea pigs by diethylnitrosamine, J. Natl. Cancer Inst. 43:833.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • Michael R. Price
    • 1
  • Robert W. Baldwin
    • 1
  1. 1.Cancer Research Campaign LaboratoriesUniversity of NottinghamNottinghamEngland

Personalised recommendations